Page last updated: 2024-09-02

exp3174 and thapsigargin

exp3174 has been researched along with thapsigargin in 1 studies

Compound Research Comparison

Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010)
(exp3174)
Studies
(thapsigargin)
Trials
(thapsigargin)
Recent Studies (post-2010) (thapsigargin)
23629435,2343918

Protein Interaction Comparison

ProteinTaxonomyexp3174 (IC50)thapsigargin (IC50)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1Oryctolagus cuniculus (rabbit)0.002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arguin, G; Auger-Messier, M; Chaloux, B; Escher, E; Guillemette, G; Leduc, R1

Other Studies

1 other study(ies) available for exp3174 and thapsigargin

ArticleYear
Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.
    Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:12

    Topics: Angiotensin II; Antihypertensive Agents; Calcium; Calcium Channels; Calcium Signaling; Cell Line; Down-Regulation; Embryo, Mammalian; Humans; Imidazoles; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Losartan; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetrazoles; Thapsigargin

2004